🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Acthar Gel was first approved by the Food and Drug Administration in 1952. ...
Status
Completed
Location
Alabama Neurology Associates
Start Date
2015-11-24
Trial ID
NCT02633033
ATLAS study is a clinical trial to evaluate the potential role of subcutane...
Status
Unknown
Location
Byers Eye Institute, Stanford University
Start Date
2019-01-01
Trial ID
NCT03465111
Treatments Being Tested
The primary objective of this study is to determine if monthly pulse doses ...
Status
Terminated
Location
Weill Cornell Medicine
Start Date
2016-06
Trial ID
NCT02446886
Treatments Being Tested
Sarcoidosis is a multisystem granulomatous disease that can affect nearly a...
Status
Unknown
Location
New England Retina Associates
Start Date
2018-04-01
Trial ID
NCT03473964
Treatments Being Tested
About 213 people with ALS will participate in this study. There will be loc...
Status
Terminated
Location
Neuromuscular Research Center
Start Date
2017-06-22
Trial ID
NCT03068754
This study is being performed to evaluate the potential efficacy and safety...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02113735
Treatments Being Tested
The purpose of this pilot study is to assess the safety and efficacy of Act...
Status
Withdrawn
Location
Phoenix Neurological Associates
Start Date
2015-08
Trial ID
NCT02574962
Treatments Being Tested
West syndrome (WS) is a specific type of epilepsy (or seizure disorder) tha...
Status
Terminated
Location
Ann & Robert H. Lurie Children's Hospital of Chicago
Start Date
2011-07
Trial ID
NCT01367964
Treatments Being Tested
This is a pilot study to measure levels of albumin and inflammatory cytokin...
Status
Completed
Location
Wilmer Eye Institute, Johns Hopkins Hospital
Start Date
2019-08-19
Trial ID
NCT03727776
Treatments Being Tested